FDA Panel Votes On Perjeta For Pre-Surgical HER2 Breast Cancer Treatment

Art © Pam Stephan Imagine having a drug that is able to shrink a breast tumor so efficiently that your surgeon can no longer find it. Imagine benefiting from a drug that targets your cancer and is less toxic to your other tissues. Imagine finding the "Off" switch to an aggressive cancer and shutting it down - permanently. Breast cancer patients may soon have access to that drug - Perjeta (Pertuzumab) - for all stages...Read Full Post
Source: About.com Breast Cancer - Category: Cancer & Oncology Source Type: news